Kessler Topaz Wins Lead In Cancer Drug Stock-Drop Suit
Kessler Topaz Meltzer & Check LLP and its investor client on Friday secured the roles of lead counsel and plaintiff in a proposed securities class action against Tesaro Inc. blaming the...To view the full article, register now.
Already a subscriber? Click here to view full article